Cleared Traditional

K221737 - InstaFill Graft Delivery System, SIGNIFY Bioactive (FDA 510(k) Clearance)

Aug 2022
Decision
57d
Days
Class 2
Risk

K221737 is an FDA 510(k) clearance for the InstaFill Graft Delivery System, SIGNIFY Bioactive. This device is classified as a Syringe, Piston (Class II - Special Controls, product code FMF).

Submitted by Globus Medical, Inc. (Audubon, US). The FDA issued a Cleared decision on August 11, 2022, 57 days after receiving the submission on June 15, 2022.

This device falls under the General & Plastic Surgery FDA review panel. Regulated under 21 CFR 880.5860.

Submission Details

510(k) Number K221737 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 15, 2022
Decision Date August 11, 2022
Days to Decision 57 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF

Device Classification

Product Code FMF — Syringe, Piston
Device Class Class II - Special Controls
CFR Regulation 21 CFR 880.5860

Similar Devices — FMF Syringe, Piston

All 19
Verisafe Safety Retractable Insulin Syringes
K250192 · Promisemed Hangzhou Meditech Co., Ltd. · Dec 2025
Merit Syringe
K250853 · Merit Medical Systems, Inc. · Nov 2025
Monoject™ 1mL Tuberculin Syringe Luer-Lock Tip (1180100777)
K243660 · Cardinalhealth · Aug 2025
BD Plastipak™ Syringe
K251350 · Becton, Dickinson and Company · Jul 2025
GraftGun Universal Graft Delivery System (GDS)
K243580 · SurGenTec, LLC · Feb 2025
Medline Luer Lock Syringes
K230235 · Medline Industries, LP · Feb 2024